Hyperbaric Oxygen Therapy and Neurodegenerative Disease
Are you curious about the link between hyperbaric oxygen therapy and neurodegenerative diseases?
This blog tackles just that. The frequency of age-related problems, such as neurodegenerative diseases, is increasing in tandem with the rise in the average life expectancy of the population as a whole.
There are millions of people all over the world who suffer from neurodegenerative diseases. The most frequent forms of neurodegenerative disorders are Alzheimer’s and Parkinson’s diseases.
According to a survey from the Alzheimer’s Disease Association in 2022, it is estimated that the number of persons living with Alzheimer’s disease in the United States might reach as high as 6.2 million.
According to the Parkinson’s Foundation, the number of people living with Parkinson’s disease in the United States is close to one million.
More and more research points to Hyperbaric Oxygen Therapy (HBOT) as an effective treatment for neurodegenerative diseases.
Before its widespread use as a treatment for decompression sickness in the nineteenth century, hyperbaric oxygen therapy was used to treat a wide range of medical ailments, beginning in 1662.
HBOT has been particularly helpful in wound healing because it amplifies the oxygen transport gradients along hypoxic wounds, promoting angiogenesis and wound healing processes (regeneration of blood vessels).
Patients who have suffered a stroke or traumatic brain injury may benefit from hyperbaric oxygen therapy, which has also been demonstrated to enhance cognitive abilities in people in good health.
A growing number of studies in the last few decades have linked HBOT to the treatment of neurodegenerative diseases and vascular dementias by increasing oxygen supply and tissue oxygen partial pressure (pO2), relieving fluid buildup, decreasing intracranial pressure, promoting tissue healing and angiogenesis, improving metabolism, reducing cell death, alleviating oxidative stress, increasing mitochondrial function.